Viewing Study NCT05455294


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-25 @ 5:33 PM
Study NCT ID: NCT05455294
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-29
First Post: 2022-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Sponsor: Jacqueline Garcia, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Malignancy View
None Myelodysplastic Syndromes View
None Myelofibrosis View
None Acute Myeloid Leukemia View
None Myeloproliferative Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myeloid Malignancy View
None Myelodysplastic Syndromes View
None Myelofibrosis View
None Acute Myeloid Leukemia View
None Myeloproliferative Neoplasm View
None MDS-myeloproliferative neoplasm View